Avruch J, Khokhlatchev A, Kyriakis J M, Luo Z, Tzivion G, Vavvas D, Zhang X F
Diabetes Unit and Medical Services, Massachusetts General Hospital, Boston 02114, USA.
Recent Prog Horm Res. 2001;56:127-55. doi: 10.1210/rp.56.1.127.
A continuing focus of our work has been an effort to understand the signal transduction pathways through which insulin achieves its cellular actions. In the mid-1970s, we and others observed that insulin promoted an increase in Ser/Thr phosphorylation of a subset of cellular proteins. This finding was unanticipated, inasmuch as nearly all of the actions of insulin then known appeared to result from protein dephosphorylation. In fact, nearly 15 years elapsed before any physiologic response to insulin attributable to stimulated (Ser/Thr) phosphorylation was established. Nevertheless, based on the hypothesis that insulin-stimulated Ser/Thr phosphorylation reflected the activation of protein (Ser/Thr) kinases downstream of the insulin receptor, we sought to detect and purify these putative, insulin-responsive protein (Ser/Thr) kinases. Our effort was based on the presumption that an understanding of the mechanism for their activation would provide an entry into the biochemical reactions through which the insulin receptor activated its downstream effectors. To a degree that, in retrospect, is surprising, this goal was accomplished, much in the way originally envisioned. It is now well known that receptor tyrosine kinases (RTKs) recruit a large network of protein (Ser/Thr) kinases to execute their cellular programs. The first of these insulin-activated protein kinase networks to be fully elucidated was the Ras-Raf-mitogen-activated protein kinase (MAPK) cascade. This pathway is a central effector of cellular differentiation in development; moreover, its inappropriate and continuous activation provides a potent promitogenic force and is a very common occurrence in human cancers. Conversely, this pathway contributes minimally, if at all, to insulin's program of metabolic regulation. Nevertheless, the importance of the Ras-MAPK pathway in metazoan biology and human malignancies has impelled us to an ongoing analysis of the functions and regulation of Ras and Raf. This chapter will summarize briefly the way in which work from this and other laboratories on insulin signaling led to the discovery of the mammalian MAP kinase cascade and, in turn, to the identification of unique role of the Raf kinases in RTK activation of this protein (Ser/Thr) kinase cascade. We will then review in more detail current understanding of the biochemical mechanism through which the Ras proto-oncogene, in collaboration with the 14-3-3 protein and other protein kinases, initiates activation of the Raf kinase.
我们工作的一个持续重点是努力了解胰岛素实现其细胞作用的信号转导途径。20世纪70年代中期,我们和其他人观察到胰岛素促进了细胞内一部分蛋白质的丝氨酸/苏氨酸磷酸化增加。这一发现出人意料,因为当时已知的几乎所有胰岛素作用似乎都是由蛋白质去磷酸化导致的。事实上,在确定任何归因于刺激(丝氨酸/苏氨酸)磷酸化的胰岛素生理反应之前,差不多过去了15年。尽管如此,基于胰岛素刺激的丝氨酸/苏氨酸磷酸化反映胰岛素受体下游蛋白质(丝氨酸/苏氨酸)激酶激活的假设,我们试图检测并纯化这些假定的、对胰岛素有反应的蛋白质(丝氨酸/苏氨酸)激酶。我们的努力基于这样一种推测,即了解它们的激活机制将为进入胰岛素受体激活其下游效应器的生化反应提供切入点。回顾起来,令人惊讶的是,这个目标在很大程度上按照最初设想的方式实现了。现在众所周知,受体酪氨酸激酶(RTK)招募大量蛋白质(丝氨酸/苏氨酸)激酶网络来执行其细胞程序。第一个被完全阐明的胰岛素激活的蛋白质激酶网络是Ras-Raf-丝裂原活化蛋白激酶(MAPK)级联反应。这条途径是发育过程中细胞分化的核心效应器;此外,其不适当和持续的激活提供了强大的促有丝分裂力量,在人类癌症中非常常见。相反,这条途径对胰岛素的代谢调节程序贡献极小,如果有贡献的话。然而,Ras-MAPK途径在多细胞生物生物学和人类恶性肿瘤中的重要性促使我们持续分析Ras和Raf的功能及调节。本章将简要总结本实验室和其他实验室关于胰岛素信号传导的研究如何导致哺乳动物MAP激酶级联反应的发现,进而确定Raf激酶在RTK激活这个蛋白质(丝氨酸/苏氨酸)激酶级联反应中的独特作用。然后,我们将更详细地回顾目前对Ras原癌基因与14-3-3蛋白及其他蛋白激酶协同作用启动Raf激酶激活的生化机制的理解。